Information  X 
Enter a valid email address

ViaLogy PLC (VIY)

  Print      Mail a friend       Annual reports

Thursday 03 July, 2014

ViaLogy PLC

Result of EGM

RNS Number : 3708L
ViaLogy PLC
03 July 2014

3 July 2014

ViaLogy PLC



Result of General Meeting


The Company announces that, at the General Meeting of the Company held earlier today, all resolutions were duly passed.


Accordingly, the following proposals become unconditional in all respects upon Admission of the Enlarged Ordinary Share Capital to trading on AIM, for which application has been made and is expected to occur at 8.00 a.m. on 4 July 2014:


·    the acquisition by the Company of the entire issued share capital of Premaitha Health Limited, resulting in the admission of 95,454,545 Consideration Shares


·    the Placing, resulting in the admission of 59,090,909 Placing Shares


·    the Open Offer, resulting in the admission of 6,723,651 Open Offer Shares


·    the Share Consolidation, resulting in the Company's Existing Ordinary Share Capital being consolidated into 26,894,601 New Ordinary Shares with a nominal value of 10 pence each


·    New Board structure:

David Evans - Non-Executive Chairman

Dr Stephen Little - Chief Executive Officer

Peter Collins  - Chief Commercial Officer

Mark Collingbourne - Finance Director

Dr Charles Roberts - Non-Executive Director

Adam Reynolds - Non-Executive Director

Nick Mustoe - Non-Executive Director



The Enlarged Ordinary Share Capital of the Company, comprising 188,163,709 New Ordinary Shares, will trade under the ISIN GB00BN31ZD89. 


The change of the Company's name to Premaitha Health plc (AIM: NIPT), will become effective upon the registration of the Company's change of name at Companies House. A further announcement will be made in due course.


All of the defined terms in this announcement have the same meaning as in the Circular published by the Company and sent to shareholders on 13 June 2014.  A copy can also be viewed on the Company's website.



Total Voting Rights

For the purposes of the Disclosure and Transparency Rules, the total number of voting rights in the Company with effect from 4 July 2014 will be 188,163,709. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.





ViaLogy PLC

Mark Collingbourne



Tel: +44 1620 810 183


Cairn Financial Advisers LLP


Liam Murray

Avi Robinson




+44 20 7148 7900


Panmure Gordon (UK) Limited


Robert Naylor

Freddy Crossley


+44 20 7886 2500



This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t